NYSE:PTN
Palatin Technologies Inc Stock News
$1.82
+0.100 (+5.81%)
At Close: Apr 26, 2024
Zendesk, Quotient, + 40 Stocks Moving In Friday's Mid-Day Session
04:07pm, Friday, 24'th Jun 2022 Benzinga
Gainers
USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider.
ToughBu
Zendesk, CalAmp, + 20 Stocks Moving In Friday's Pre-Market Session
11:35am, Friday, 24'th Jun 2022 Benzinga
Gainers
ToughBuilt Industries, Inc. (NASDAQ: TBLT) rose 58% to $2.75 in pre-market trading after jumping 26% on Thursday. ToughBuilt Industries reported closing of $6 million public offering.
Zendes
Palatin Technologies, Inc. (PTN) CEO Carl Spana on Q3 2022 Results - Earnings Call Transcript
01:27pm, Tuesday, 17'th May 2022
Palatin Technologies, Inc. (NYSE:PTN ) Q3 2022 Results Conference Call May 17, 2022 11:00 AM ET Company Participants Carl Spana - President and Chief Executive Officer Steve Wills - Executive Vice Pre
Palatin Technologies, Inc. (PTN) Reports Q3 Loss, Misses Revenue Estimates
12:45pm, Tuesday, 17'th May 2022 Zacks Investment Research
Palatin Technologies, Inc. (PTN) delivered earnings and revenue surprises of 0% and 62.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Palatin Technologies, Inc. (PTN) Reports Q3 Loss, Misses Revenue Estimates
09:47am, Tuesday, 17'th May 2022
Palatin Technologies, Inc. (PTN) delivered earnings and revenue surprises of 0% and 62.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Proton Capital Corp. Completes Initial Public Offering as a Capital Pool Company
05:18pm, Monday, 16'th May 2022 GlobeNewswire Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWS WIRES
PhaseBio Pharmaceuticals (PHAS) Reports Q1 Loss, Misses Revenue Estimates
11:15am, Monday, 16'th May 2022 Zacks Investment Research
PhaseBio Pharmaceuticals (PHAS) delivered earnings and revenue surprises of 65.67% and 98%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
12:42pm, Thursday, 12'th May 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
BridgeBio Inks Licensing Pact With Bristol Myers For SHP2 Inhibitor In Oncology
BridgeBio Pharma Inc
Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Tops Revenue Estimates
12:15pm, Thursday, 12'th May 2022 Zacks Investment Research
Liquidia Technologies, Inc. (LQDA) delivered earnings and revenue surprises of -50% and 7.12%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stoc
Palatin to Report Third Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on May 17, 2022
09:02am, Wednesday, 11'th May 2022
CRANBURY, N.J. , May 11, 2022 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its third quarter, fiscal year 2022 operating results on Tuesday, May 17, 2022, before the o
Intra-Cellular Therapies (ITCI) Reports Q1 Loss, Tops Revenue Estimates
12:45pm, Tuesday, 10'th May 2022 Zacks Investment Research
Intra-Cellular (ITCI) delivered earnings and revenue surprises of 16.13% and 5.16%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Berkeley Lights, Inc. (BLI) Reports Q1 Loss, Lags Revenue Estimates
09:15pm, Monday, 09'th May 2022 Zacks Investment Research
Berkeley Lights, Inc. (BLI) delivered earnings and revenue surprises of -3.23% and 1.60%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Curis (CRIS) Reports Q1 Loss, Misses Revenue Estimates
10:05pm, Thursday, 05'th May 2022 Zacks Investment Research
Curis (CRIS) delivered earnings and revenue surprises of -5.88% and 6.71%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Palatin to Present at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Conference
01:02pm, Monday, 02'nd May 2022
Posters highlight Palatin's ocular research and PL9643 Phase 2 clinical data CRANBURY, N.J. , May 2, 2022 /PRNewswire/ -- Palatin Technologies, Inc. ("Palatin") (NYSE American: PTN), a biopharmaceutic
Best Penny Stocks Today? 4 To Buy For Under $1 According To Reddit
04:38pm, Monday, 18'th Apr 2022 PennyStocks
Popular Reddit penny stocks to watch under $1.
The post Best Penny Stocks Today? 4 To Buy For Under $1 According To Reddit appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto